featured
MY APPROACH to Malignant Melanoma
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Memorial Sloan Kettering Cancer Center. Risk of Sentinel Lymph Node Metastasis. Accessed December 14, 2021.
- Goldstein AM. Familial melanoma, pancreatic cancer and germline CDKN2A mutations. Hum Mutat. 2004;23(6):630.
- Zager JS, Hochwald SN, Marzban SS, et al. Shave biopsy is a safe and accurate method for the initial evaluation of melanoma. J Am Coll Surg. 2011;212(4):454-460; discussion 460-462.
- Privalle A, Havighurst T, Kim K, et al. Number of skin biopsies needed per malignancy: Comparing the use of skin biopsies among dermatologists and nondermatologist clinicians. J Am Acad Dermatol. 2020;82(1):110-116.
- Dawn ME, Dawn AG, Miller SJ. Mohs surgery for the treatment of melanoma in situ: a review. Dermatol Surg. 2007;33(4):395-402.
- Kunishige JH, Brodland DG, Zitelli JA. Surgical margins for melanoma in situ. J Am Acad Dermatol. 2012;66(3):438-444.
- Bene NI, Healy C, Coldiron BM. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases. Dermatol Surg. 2008;34(5):660-664.
- Coldiron BM. Sentinel node biopsy: who needs it? Int J Dermatol. 2000;39(11):807-811.
- Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211-2222.
Disclosure statements are available on the authors' profiles: